Sarraf Pasha (CIK 2059447) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-10). Recent activity: Buy CUE (21,800 shares), Buy CUE (4,229 shares), Buy CUE (77,148 shares), Buy CUE (86,947 shares), Buy CUE (78,116 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Cue Biopharma, Inc. (CUE) | Director | Buy | 21,800 | $0 |
| 2026-01-02 | Cue Biopharma, Inc. (CUE) | Director | Buy | 4,229 | $1,311 |
| 2026-01-02 | Cue Biopharma, Inc. (CUE) | Director | Buy | 77,148 | $23,144 |
| 2026-01-02 | Cue Biopharma, Inc. (CUE) | Director | Buy | 86,947 | $27,823 |
| 2026-01-02 | Cue Biopharma, Inc. (CUE) | Director | Buy | 78,116 | $24,216 |
| 2026-01-02 | Cue Biopharma, Inc. (CUE) | Director | Buy | 77,417 | $23,225 |
Source: SEC Form 4 filings · as of 2026-07-10